CLINICAL_TRIALS ClinicalTrials.gov record update

Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet's Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00167583
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:55.623115+00:00
Published At: 2018-05-17T00:00:00+00:00
Record Updated At: 2018-05-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Behcet\u0027s Disease", "Panuveitis", "Posterior Uveitis", "Retinal Vasculitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-05-17"
protocolSection.identificationModule.nctId: "NCT00167583"
protocolSection.identificationModule.officialTitle: "Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet\u0027s Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.